An artificially designed elastin-like recombinant polypeptide improves aging skin.

Area of Science:

• Dermatology
• Biotechnology
• Cosmetic Science

Background:

• Elastin promotes epidermal regeneration and remodeling, crucial for delaying skin aging.
• Native elastin proteins are too large for skin absorption, limiting their anti-aging applications.
• A novel approach is needed to leverage elastin's benefits for topical anti-aging treatments.

Purpose of the Study:

• To evaluate the efficacy of a novel, skin-absorbable elastin-like recombinant polypeptide (ELR) for anti-aging effects.
• To assess the impact of ELR on skin elasticity, firmness, and wrinkles.
• To determine the duration of treatment required for significant improvements.

Main Methods:

• Developed an elastin-like recombinant polypeptide (ELR) utilizing the VGVAPG hexapeptide for skin penetration.
• Conducted a 4-week study with 30 healthy Chinese Han female participants.
• Measured skin elasticity, firmness, and crow's feet wrinkles at baseline, day 14, and day 28 using paired t-tests or Wilcoxon signed-rank tests.

Main Results:

• Significant increase in skin elasticity observed after 28 days of ELR use (P=0.024).
• Marked reduction in wrinkle count, volume, and area for crow's feet after 14 and 28 days (P<0.001).
• No statistically significant change in skin firmness was detected during the study period.

Conclusions:

• Continuous application of ELR effectively enhances skin elasticity.
• ELR significantly reduces the visible signs of aging, specifically wrinkles.
• This absorbable polypeptide represents a promising topical agent for combating skin aging.